Compare HAE & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAE | JPC |
|---|---|---|
| Founded | 1971 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 1996 | 2003 |
| Metric | HAE | JPC |
|---|---|---|
| Price | $59.16 | $7.79 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $84.13 | N/A |
| AVG Volume (30 Days) | 758.2K | ★ 880.3K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.54 | N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $910,373,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.23 | N/A |
| P/E Ratio | $23.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.32 | $7.22 |
| 52 Week High | $87.32 | $8.30 |
| Indicator | HAE | JPC |
|---|---|---|
| Relative Strength Index (RSI) | 55.46 | 42.93 |
| Support Level | $49.26 | $7.22 |
| Resistance Level | $62.48 | $8.25 |
| Average True Range (ATR) | 3.21 | 0.07 |
| MACD | 0.38 | -0.04 |
| Stochastic Oscillator | 85.46 | 40.11 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its primary investment objective is to provide high current income, and its secondary investment objective is total return. The fund invests a majority of its assets in preferred securities and other income-producing securities, including hybrid securities such as contingent capital securities, and the rest of its investments are made in other securities, mainly income-oriented securities such as corporate and taxable municipal debt and common equity.